In the intricate symphony of human physiology, few instruments play a more pivotal role than the heart. A marvel of ...
此次FDA批准注册标志着公司产品获得进入美国市场销售的资质,这将对产品在海外市场的推广和销售产生积极影响。然而,公告中也提到,产品在相应市场的实际销售情况将受到未来市场推广效果、海外市场政策环境变化以及汇率波动等因素的影响,目前尚无法预测对公司未来经 ...
2 天
Medical Device Network on MSNFDA clears Perfuze’s Zipline access catheter for stroke treatmentCoinciding with the FDA’s clearance for the catheter, Perfuze has also completed a €22m ($24m) financing round.
天眼查资料显示,维力医疗成立于2004年04月30日,注册资本29286.8018万人民币,法定代表人韩广源,注册地址为广州市番禺区化龙镇金湖工业城C区4号。主营业务为麻醉、导尿、泌尿外科、护理、呼吸、 血液透析 ...
在国际医疗市场中,FDA的认可无疑是一种权威背书。这意味着,该产品不仅在质量、安全性上符合严格标准,还具备进入北美市场的资质。获得FDA批准的产品能更容易地被医生推荐,患者使用,从而推动企业的销售增长。这样的认可,为维力医疗的国际化之路铺平了道路。
Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8523 ...
Basis Medical recently announced that its Seclusion catheter for the treatment of superficial vein reflux has received FDA ...
Olubadewa A. Fatunde and Win-Kuang Shen. Catheter Ablation as the First-Line Therapy for Atrial Fibrillation: Update on Evidence and Clinical Implications. CVIA. 2025. Vol. 10 (1). DOI: ...
VTAK股价已跌至52周新低0.31美元,较52周高点8.40美元下跌96%,公司正在应对充满挑战的市场环境。根据 InvestingPro 分析,尽管目前面临挑战,该公司仍保持着90.5%的高毛利率。这一显著下跌反映了RA Medical ...
Perfuze, a medtech has raised €22m. With the infusion, the company will release its catheters to select stroke centres in the US.
11 天
Zacks Investment Research on MSNSTXS Stock Tumbles Despite EMAGIN Catheter Submission for ApprovalStereotaxis STXS recently submitted an application seeking FDA regulatory clearance for its EMAGIN 5F catheter, marking a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果